Cite
Interleukin-1 Receptor Antagonist Gene (IL1RN) Variants Modulate the Cytokine Release Syndrome and Mortality of COVID-19.
MLA
Attur, Mukundan, et al. “Interleukin-1 Receptor Antagonist Gene (IL1RN) Variants Modulate the Cytokine Release Syndrome and Mortality of COVID-19.” Journal of Infectious Diseases, vol. 229, no. 6, June 2024, pp. 1740–49. EBSCOhost, https://doi.org/10.1093/infdis/jiae031.
APA
Attur, M., Petrilli, C., Adhikari, S., Iturrate, E., Li, X., Tuminello, S., Hu, N., Chakravarti, A., Beck, D., & Abramson, S. B. (2024). Interleukin-1 Receptor Antagonist Gene (IL1RN) Variants Modulate the Cytokine Release Syndrome and Mortality of COVID-19. Journal of Infectious Diseases, 229(6), 1740–1749. https://doi.org/10.1093/infdis/jiae031
Chicago
Attur, Mukundan, Christopher Petrilli, Samrachana Adhikari, Eduardo Iturrate, Xiyue Li, Stephanie Tuminello, Nan Hu, Aravinda Chakravarti, David Beck, and Steven B Abramson. 2024. “Interleukin-1 Receptor Antagonist Gene (IL1RN) Variants Modulate the Cytokine Release Syndrome and Mortality of COVID-19.” Journal of Infectious Diseases 229 (6): 1740–49. doi:10.1093/infdis/jiae031.